Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Protalix BioTherapeutics (PLX) over the last 17 years, with Q3 2025 value amounting to -$12000.0.

  • Protalix BioTherapeutics' Exchange Rate Effect fell 50000.0% to -$12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $38000.0, marking a year-over-year increase of 16785.71%. This contributed to the annual value of $25000.0 for FY2024, which is 12192.98% up from last year.
  • Per Protalix BioTherapeutics' latest filing, its Exchange Rate Effect stood at -$12000.0 for Q3 2025, which was down 50000.0% from $4000.0 recorded in Q2 2025.
  • In the past 5 years, Protalix BioTherapeutics' Exchange Rate Effect registered a high of $54000.0 during Q4 2024, and its lowest value of -$42000.0 during Q1 2023.
  • Moreover, its 5-year median value for Exchange Rate Effect was -$10000.0 (2022), whereas its average is -$9777.8.
  • In the last 5 years, Protalix BioTherapeutics' Exchange Rate Effect crashed by 90000.0% in 2022 and then surged by 30000.0% in 2024.
  • Protalix BioTherapeutics' Exchange Rate Effect (Quarter) stood at $40000.0 in 2021, then tumbled by 165.0% to -$26000.0 in 2022, then fell by 3.85% to -$27000.0 in 2023, then soared by 300.0% to $54000.0 in 2024, then crashed by 122.22% to -$12000.0 in 2025.
  • Its Exchange Rate Effect was -$12000.0 in Q3 2025, compared to $4000.0 in Q2 2025 and -$8000.0 in Q1 2025.